Delix Therapeutics

About:

Delix Therapeutics focuses on harnessing the power of psychoplastogens novel neuroplasticity-promoting therapeutic.

Website: https://www.delixtherapeutics.com

Top Investors: RA Capital Management, Gaingels, National Institute on Drug Abuse (NIDA), U.S. Department of Defense, Saya Bio

Description:

Delix Therapeutics is a neuroscience company focused on harnessing the power of psychoplastogens—novel neuroplasticity-promoting therapeutics—to better treat mental health disorders at scale. The company was founded in 2019 and is headquartered in Boston, Massachusetts.